Transaction · 0001193125-26-381992

Fisher Patrick

Fisher Patrick, PRES, GLR, reported an open-market or private sale at Orthofix Medical Inc. involving 150.000000 shares for an estimated $1408.50. Reported holdings after the transaction were 51069.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SPRES, GLR
OFIXOrthofix Medical Inc.
Filing timeSep 03
Trade dateSep 01, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$9.31
Pre-filing
1mo ago +26.7%1w ago +3.2%1d ago +0.9%
Returns since
7d +0.0%30d +0.0%90d +0.0%180d +0.0%1y +0.0%

OFIX price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
OFIX since 2026-09-03Filed yesterday · 1 day of post-filing data
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001193125-26-381992
Common Stock
Transaction date
Sep 01, 2026
Filed Sep 03, 2026, 08:41 PM · 2d delay
Shares
150 sh
$939 per share
Estimated value
-$140k
Computed from shares × price
Holdings after
51.0k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

President, Global Limb Recon

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2026.

  2. F2

    Includes 36,028 previously reported restricted stock units.

Original filing · 0001193125-26-381992
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

OFIX